Statistics for Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1.
Total visits
| views | |
|---|---|
| Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1. | 268 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms674154.pdf | 323 |
| java.util.UUID:970e92fd-2638-4361-9761-5a4606c3d37f | 69 |
| java.util.UUID:39d246ee-0cab-44f8-bfca-b4b332b9c80c | 9 |
Top country views
| views | |
|---|---|
| United States | 204 |
| Germany | 17 |
| Sweden | 7 |
| Ukraine | 6 |
| United Kingdom | 4 |
| Russia | 4 |
| Canada | 2 |
| China | 1 |
| Greece | 1 |
| Italy | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 64 |
| Fairfield | 32 |
| Ann Arbor | 15 |
| Houston | 15 |
| Kiez | 15 |
| Cambridge | 12 |
| White Plains | 10 |
| Jacksonville | 7 |
| Kiev | 6 |
| Stockholm | 6 |
| San Francisco | 5 |
| Saint Petersburg | 3 |
| Gunzenhausen | 2 |
| Lake Mary | 2 |
| Toronto | 2 |
| Washington | 2 |
| Alexandria | 1 |
| Athens | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Brooklyn | 1 |
| Chicago | 1 |
| Genova | 1 |
| Indianapolis | 1 |
| Moscow | 1 |
| Motala | 1 |
| Overland Park | 1 |
| Philadelphia | 1 |
| Scottsdale | 1 |
| Seremban | 1 |